Program
SSS17
A development code. Also written as “[14C]SSS17” and “SSS17 Capsule (6 Dose Levels)”.
Its studies are mostly in Anemia, led by 3SBio.
Furthest: phase 2, since May 29, 20256 company-led studies, 2 open or running
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| 3SBio | 62 open or running | phase 2since May 29, 2025 | Mar 19, 2020 | none ahead |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Mar 19, 2020First study: phase 1 study in Anemia in Chronic Kidney DiseasesFirst studyNCT04317833 · 65 enrolled · China
- May 17, 2021Phase 1 study in Anemia in Chronic Kidney DiseasesNCT04893187 · 76 enrolled · China
- May 29, 2025Phase 2 study in Postoperative AnemiaNCT07007936 · 90 planned · China
- Jun 3, 2025Phase 2 study in Anemia in Pre-Dialysis PatientsNCT07014631 · 86 enrolled · China
- Jun 5, 20252 phase 1 studies in Healthy Subjects (HS)NCT07024888, NCT07025915
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 6 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07025915Healthy Subjects (HS) | 1 | Not yet recruiting | Jul 2025 | 6 |
| NCT07024888Healthy Subjects (HS) · China | 1 | Completed | May 28, 2025 | 36 |
| NCT07014631Anemia in Pre-Dialysis Patients · China | 2 | Completed | Dec 12, 2024 | 86 |
| NCT07007936Postoperative Anemia · China | 2 | Not yet recruiting | Apr 2026 | 90 |
| NCT04893187Anemia in Chronic Kidney Diseases · China | 1 | UNKNOWN | Dec 31, 2022 | 76 |
| NCT04317833Anemia in Chronic Kidney Diseases · China | 1 | UNKNOWN | Jun 30, 2021 | 65 |
How it is read
Names in the registry
- “SSS17”, 4 entries
- “[14C]SSS17”, 1 entry
- “SSS17 Capsule (6 Dose Levels)”, 1 entry
Codes read as this program: SSS17.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.